美国Tangent Medical   
为静脉注射治疗。成立于2009年分拆出来的大学，密歇根州的医疗创新中心，本公司的主导产品，NovaCath™安全静脉留置针系统，是基于大量的临床浸泡和研究的医务工作者和患者的需求。这种下一代系统将导管设计，功能和性能建立了新的标准。

Tangent Medical Technologies, Inc.
Tangent Medical is committed to the development and commercialization of innovative products for IV therapy. Founded in 2009 as a spin-out of the University of Michigan’s Medical Innovation Center, the Company’s lead product, the NovaCath™ Secure IV Catheter System, is based on extensive clinical immersion and research into the needs of both healthcare workers and patients. This next-generation system will establish a new standard in catheter design, functionality, and performance.